Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Ardelyx Announces Publication Of 52-week Phase 3 PHREEDOM Trial In American Society Of Nephrology Journal, Kidney360


RTTNews | Sep 3, 2021 08:04AM EDT

08:04 Friday, September 3, 2021 (RTTNews) - Ardelyx Announces Publication Of 52-week Phase 3 PHREEDOM Trial In American Society Of Nephrology Journal, Kidney360

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC